Results 61 to 70 of about 4,316 (128)

Pancreatic mesenchymal neoplasms diagnosed by endoscopic ultrasound-guided fine needle aspiration/biopsy: A concise review

open access: yesHuman Pathology Reports
The mesenchymal tumors of the pancreas account for approximately 1–2% of all pancreatic neoplasms and they are not commonly encountered in our daily practice.
Qun Wang   +4 more
doaj   +1 more source

Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report

open access: yesBMC Urology, 2006
Background Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers.
Wehrli Bret M   +3 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Uterine lymphangioleiomyomatosis in a premenopausal woman with tuberous sclerosis: A case report

open access: yesCase Reports in Women's Health
Lymphangioleiomyomatosis is a rare disease characterized by abnormal smooth muscle cell growth. It primarily occurs in the lungs but can also rarely occur in other organs, in which case it is classified as extrapulmonary lymphangioleiomyomatosis.
Eun Min Lee   +3 more
doaj   +1 more source

Hepatic and perihepatic PEComas: A study describing a series of five rare cases

open access: yesIndian Journal of Pathology and Microbiology
Background: Perivascular epithelioid cell tumors (PEComas) encompass a group of rare mesenchymal neoplasms, with dual melanocytic and muscular differentiation.
P Vijayanirmala   +9 more
doaj   +1 more source

TSC2-mutated perivascular epithelioid cell tumor with partial response to mTOR inhibition: a case report and literature review

open access: yesDiscover Oncology
Perivascular epithelioid cell tumors (PEComas), rare mesenchymal neoplasms with heterogeneous behavior, are molecularly characterized by TSC2 inactivation driving mammalian target of rapamycin (mTOR) pathway activation.
Xiaopeng Suo   +5 more
doaj   +1 more source

MiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa

open access: yesNature Communications
Perivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors lacking a molecular classification to guide therapy. Here we perform comprehensive multi-omic profiling of an unselected PEComa cohort.
Justine Gantzer   +34 more
doaj   +1 more source

Home - About - Disclaimer - Privacy